Legend Biotech Adr Rep Corp.
Legend Biotech, founded 2014, develops and commercializes cutting‑edge CAR‑T therapies for multiple myeloma and a broad oncology portfolio. Its lead product Cilta‑cel (cilta‑celf) is partnered with Janssen Biotech, and it holds a Novartis license for DLL3‑targeted CAR‑T.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Family Planning Centers
- Employees: 2,900
- HQ: Somerset
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.